AI Engines For more Details: Perplexity Kagi Labs You
| Rank | Probiotic | Impact |
|---|
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
| 📓 Direct Citations | 👪👶 Indirect Citations | Taxonomy | Rank | Effect |
|---|---|---|---|---|
| 0 | 1 | Enterobacteriaceae | family | Decreases |
| 1 | 0 | Shigella | genus | Decreases |
| 0 | 1 | Proteus | genus | Decreases |
| 0 | 1 | environmental samples | no rank | Decreases |
| 0 | 1 | unclassified Shigella | no rank | Decreases |
| 1 | 0 | Proteus mirabilis | species | Decreases |
| 1 | 0 | Yersinia pestis | species | Decreases |
| 0 | 1 | Shigella flexneri | species | Decreases |
| 0 | 1 | Shigella dysenteriae | species | Decreases |
| 0 | 1 | Shigella boydii | species | Decreases |
| 0 | 1 | Shigella sonnei | species | Decreases |
| 0 | 1 | Yersinia pseudotuberculosis complex | species group | Decreases |
| 0 | 1 | Proteus mirabilis ATCC 29906 | strain | Decreases |
| 0 | 1 | Proteus mirabilis BB2000 | strain | Decreases |
| 0 | 1 | Proteus mirabilis C05028 | strain | Decreases |
| 0 | 1 | Proteus mirabilis HI4320 | strain | Decreases |
| 0 | 1 | Proteus mirabilis PR03 | strain | Decreases |
| 0 | 1 | Proteus mirabilis WGLW4 | strain | Decreases |
| 0 | 1 | Proteus mirabilis WGLW6 | strain | Decreases |
| 0 | 1 | Yersinia pestis subsp. microtus | subspecies | Decreases |
| 0 | 1 | Yersinia pestis subsp. pestis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
| Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
|---|---|---|---|
| Allergies | 0.5 | 0 | 0 |
| Allergy to milk products | 0 | 0 | |
| Alzheimer's disease | 0.5 | 0.5 | 0 |
| Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 0 | 0 |
| Ankylosing spondylitis | 0.5 | 0 | 0 |
| Anorexia Nervosa | 0 | 0 | |
| Asthma | 0 | 0 | 0 |
| Atherosclerosis | 0.8 | 0.8 | |
| Atrial fibrillation | 0.5 | -0.5 | |
| Autism | 0.5 | 1 | -1 |
| Autoimmune Disease | 0.5 | 0.5 | |
| benign prostatic hyperplasia | 0.5 | 0.5 | |
| Biofilm | 1 | 1 | |
| Bipolar Disorder | 0.5 | 0.5 | |
| Brain Trauma | 0.5 | 0.5 | |
| Breast Cancer | 0.3 | -0.3 | |
| Celiac Disease | 0 | 0 | 0 |
| Chronic Kidney Disease | 0.5 | 0.5 | |
| Chronic Lyme | 0 | 0 | |
| Chronic Obstructive Pulmonary Disease (COPD) | 0 | 0 | |
| Coagulation / Micro clot triggering bacteria | 0.5 | 0.5 | |
| Colorectal Cancer | 1 | 1 | |
| Constipation | 0.5 | 0.5 | |
| Coronary artery disease | 0.5 | 0.5 | |
| COVID-19 | 0.5 | 0.5 | |
| Crohn's Disease | 1.3 | 1.3 | |
| cystic fibrosis | 0 | 0 | |
| deep vein thrombosis | 0.8 | 0.8 | |
| Depression | 0.5 | 0.5 | 0 |
| Eczema | 0.5 | 0.5 | |
| Endometriosis | 0.5 | 0.5 | |
| Epilepsy | 0.5 | 0.5 | |
| erectile dysfunction | 0.5 | 0.5 | |
| Functional constipation / chronic idiopathic constipation | 0.5 | 0.5 | |
| gallstone disease (gsd) | 0.5 | 0.5 | |
| Generalized anxiety disorder | 0.5 | 0.5 | |
| Gout | 0 | 0.5 | 0 |
| Graves' disease | 0 | 0 | |
| Heart Failure | 0.5 | 0.5 | |
| Hidradenitis Suppurativa | 0.5 | 0.5 | |
| High Histamine/low DAO | 0.8 | 0.8 | |
| hyperglycemia | 0.5 | 0.5 | |
| hypertension (High Blood Pressure | 0.5 | 0.5 | |
| Hypothyroidism | 0.3 | 0.3 | |
| Hypoxia | 0.5 | 0.5 | |
| IgA nephropathy (IgAN) | 0 | 0 | |
| Inflammatory Bowel Disease | 1.6 | 1.6 | |
| Irritable Bowel Syndrome | 0.8 | 0.8 | |
| ischemic stroke | 0.5 | -0.5 | |
| Liver Cirrhosis | 0 | 0 | |
| Long COVID | 0.3 | 0.3 | |
| Lung Cancer | 0.5 | 0.5 | |
| Lymphoma | 0.5 | 0.5 | |
| Mast Cell Issues / mastitis | 0.5 | 0.5 | |
| Metabolic Syndrome | 0.5 | 0.5 | |
| Mood Disorders | 0.5 | 0.5 | 0 |
| Multiple Sclerosis | 0.5 | 0.5 | |
| myasthenia gravis | 0.5 | 0 | 0 |
| Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 0.3 | 0.67 |
| Obesity | 1 | 1 | |
| obsessive-compulsive disorder | 0 | 0 | |
| Osteoporosis | 0.5 | 0.5 | |
| pancreatic cancer | 0 | 0 | |
| Parkinson's Disease | 1.3 | 1.3 | |
| Polycystic ovary syndrome | 0.5 | 0.5 | |
| Postural orthostatic tachycardia syndrome | 0 | 0 | |
| Primary sclerosing cholangitis | 0.5 | 0.5 | |
| rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.3 | 1.3 | |
| Schizophrenia | 0 | 0 | 0 |
| scoliosis | 0.3 | 0.3 | |
| sensorineural hearing loss | 0.5 | 0.5 | |
| Sjögren syndrome | 0.5 | 0.5 | |
| Sleep Apnea | 0.5 | 0.5 | |
| Small Intestinal Bacterial Overgrowth (SIBO) | 0.3 | 0.3 | |
| Stress / posttraumatic stress disorder | 0.5 | 0.5 | |
| Systemic Lupus Erythematosus | 0.5 | 0.5 | |
| Type 1 Diabetes | 0.5 | 0.5 | |
| Type 2 Diabetes | 0.5 | 0.5 | |
| Ulcerative colitis | 1 | 1 | |
| Unhealthy Ageing | 0 | 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
